Extraordinary meeting of the Committee for Medicinal Products for Human Use (CHMP): 26 September 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 26 September 2024, 10:00 (CEST) to 26 September 2024, 13:00 (CEST)

Submitted by Anonymous (not verified) on 26 September 2024 - 9:00

Extraordinary meeting of the Committee for Medicinal Products for Human Use (CHMP): 26 September 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 26 September 2024, 10:00 (CEST) to 26 September 2024, 13:00 (CEST)

Human medicines European public assessment report (EPAR): Giapreza, angiotensin II, Date of authorisation: 23/08/2019, Revision: 6, Status: Authorised

Submitted by Anonymous (not verified) on 25 September 2024 - 16:18

Human medicines European public assessment report (EPAR): Giapreza, angiotensin II, Date of authorisation: 23/08/2019, Revision: 6, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More